Michael Link
Academic Appointments
- Professor, Pediatrics - Hematology & Oncology
- Member, Child Health Research Institute
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Pediatric Hematology-Oncology 725 Welch Rd MC 5798 Palo Alto, CA 94034 Tel Work (650) 723-5535 Fax (650) 498-6937Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Tel (650) 723-5535Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Hematology/Oncology/Stem Cell Transplant, Pediatric
- Pediatric Hematology-Oncology
Administrative Appointments
- President, American Society of Clinical Oncology (2011 - 2012)
- President-Elect, American Society of Clinical Oncology (2010 - 2011)
- Lydia J. Lee Professor in Pediatric Cancer, Stanford University (2003 - present)
- Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine (2000 - 2010)
- Director, Center for Cancer and Blood Diseases, Lucile Packard Children's Hospital at Stanford (2002 - 2010)
Honors and Awards
- 21st Annual W.W. Sutow Visiting Lecturer in Pediatric Oncology, MD Anderson Hospital (2013)
- Brent Eley Visiting Professor in Pediatric Oncology, University of Colorado Cancer Center and the Childrens Hospital, Denver (2009)
- Annual Memorial Lectureship, Pediatric Cancer Research Foundation (2004)
- Ben Abelson Memorial Visiting Professor, Washington University School of Medicine (2000)
- Alpha Omega Alpha, Alpha Omega Alpha (1974)
- Phi Beta Kappa, Phi Beta Kappa (1969)
Professional Education
| Fellowship: | Children's Hospital Boston MA (1979) |
| Residency: | Children's Hospital Boston MA (1976) |
| Internship: | Children's Hospital Boston MA (1975) |
| Board Certification: | Pediatric Hematology-Oncology, American Board of Pediatrics (1980) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1979) |
| Fellowship: | Dana-Farber Cancer Institute MA (1979) |
Community and International Work
- Childhood Cancer Working Group of the Global Task Force on Expanded Access to Cancer Care (GTF.CCC), International&suffix=researcher
Scientific Focus
Current Research Interests
Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.
Clinical Trials
- Not Recruiting School Response to Families Who Have Children With Cancer
- Not Recruiting Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
- Not Recruiting A Treatment-Option Study of Brentuximab Vedotin in Patients With Progression of Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma
- Not Recruiting Therapy for Pediatric Hodgkin Lymphoma
- Not Recruiting Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
Publications
- Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA. 2012; (24): 2609-16
- The impact of drug shortages on children with cancer--the example of mechlorethamine. N Engl J Med. 2012; (26): 2461-3
- Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol. 2010; (7): 1232-9
- ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained but inactivated PTEN--a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012; (3): 440-7
- Adolescent and young adult oncology. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2012; (9): 1112-50
- Chemotherapy drug shortages in the United States: genesis and potential solutions. J Clin Oncol. 2012; (7): 692-4
Help
Trial Administration